Jadhav, Vaibhav <br/><br/>
Biocompatible arsenic trioxide nanoparticles induce cell cycle arrest by p21(WAF1/CIP1) expression via epigenetic remodeling in LNCaP and PC3 cell lines.  [electronic resource] 

 -  Life sciences  Mar 2016 
 - 41-52 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0631 
<br/><br/><label>Standard No.: </label>10.1016/j.lfs.2016.02.042  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Arsenic Trioxide<br/>Arsenicals--pharmacology<br/>Biocompatible Materials--pharmacology<br/>Cell Cycle Checkpoints--drug effects<br/>Cell Line, Tumor<br/>Cyclin-Dependent Kinase Inhibitor p21--biosynthesis<br/>Dose-Response Relationship, Drug<br/>Epigenesis, Genetic--drug effects<br/>Humans<br/>Male<br/>Metal Nanoparticles--therapeutic use<br/>Oxides--pharmacology<br/>Prostatic Neoplasms--drug therapy